Stockreport

Neumora Therapeutics to Participate in Upcoming Conferences in November

Neumora Therapeutics, Inc.  (NMRA) 
PDF WATERTOWN, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline [Read more]